EcoDrugPlus

Somatostatin Receptor 5

Ensembl ID : ENSCDRG00005013911
Gene Symbol: SSTR5
3 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSCDRG00005002154
Gene Symbol: SPHK2
3 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSCDRG00005000226
Gene Symbol: S1PR1
3 Cross references
194 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSCDRG00005014484
Gene Symbol: SRD5A2
1 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSCDRG00005009367
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSCDRG00005003353
Gene Symbol: SI
3 Cross references
201 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSCDRG00005008644
Gene Symbol: TACR1
3 Cross references
271 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSCDRG00005007405
Gene Symbol: TACR2
1 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSCDRG00005014652
Gene Symbol: TACR3
3 Cross references
258 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSCDRG00005007091
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSCDRG00005003325
Gene Symbol: TBXAS1
3 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSCDRG00005005933
Gene Symbol: TBXA2R
3 Cross references
194 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).